Trial intelligence / Profile preview

GV-328 in Children With Oral Aphthosis

NCT04677062Completed

Sponsor
Universitat Internacional de Catalunya
Start
Nov 2017
Primary completion
Jun 2019
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of GV-328 in aphthous stomatitis (RAS), sponsored by Universitat Internacional de Catalunya. Primary endpoint: Level of Pain on Wong-Baker Faces Scale at 4 days. Started Nov 2017; status: completed.

02

Drugs

GV-328
03

Conditions

aphthous stomatitis (RAS)

Beyond the preview

Go deeper on NCT04677062.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04677062.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call